As reported by IPWatchdog, Moderna is facing lawsuits in the United States from biotech firms, Arbutus Biopharma Corporation and Genevant Sciences GmbH.
Both companies allege that Moderna has infringed six of their U.S. patents relating to lipid nanoparticle (“LNP”) delivery technology. LNP delivery systems are crucial for mRNA therapies like Moderna’s COVID-19 vaccine by allowing treatments to bypass the human immune system without being destroyed.
Moderna has reportedly denied all allegations and vowed to vigorously defend itself against the claims made against it in court.
The plaintiffs in this action are seeking compensation, rather than an injunction, which is typically sought in such actions. If infringement is found, compensation through damages would likely be assessed through a “reasonable royalty”.
There has been a reported surge in trademark phishing scams. The Canadian Intellectual Property Office (“CIPO”) issued a statement warning of an email phishing scam targeting members of the public by…
A few recent patent applications reveal that the Honda Element may be making its return to the automotive industry: The first patent application is a “camper for a vehicle”. The second…
Kory McDonald, the creator of “Worldle”, a geography-themed game, is advocating on behalf of all games ending in “-le”. Worldle shows a series of Google Street view images from which players…
Steve King, the former Iowa Republican Congressman, has reportedly lost his appeal attempting to overturn a copyright verdict for using the “Success Kid” meme in his 2020 campaign. The “Success…
Toyota has reportedly filed a patent application for a colour-changing paint that changes colour when exposed to specific temperatures and light sources. This technique involves painting the car…
Alaska Airlines (“Alaska”) recently lost an appeal over a trademark licensing agreement at the Court of Appeal in London, in a decision favoring Virgin Group. Alaska was ordered to pay approximately…
